Gilead to Test a Version of Remdesivir That Can Be Inhaled
Published
As scientists study the effectiveness of the drug against the coronavirus, others are exploring how to make the potential treatment easier to administer.
Full ArticlePublished
As scientists study the effectiveness of the drug against the coronavirus, others are exploring how to make the potential treatment easier to administer.
Full ArticleWatch VideoGilead Sciences announced Monday it will start human clinical trials for an inhaled version of remdesivir as a potential..
· A variant of remdesivir, one of the most promising treatments for COVID-19, has for more than a year been sold as a treatment..